SC 13G/A | 2020-02-12 | VANGUARD GROUP INC | Allergan plc | 24,506,020 | 7.5% | EDGAR |
SC 13G/A | 2020-02-10 | BlackRock Inc. | Allergan plc | 20,807,793 | 6.3% | EDGAR |
SC 13G/A | 2019-02-12 | WELLINGTON MANAGEMENT GROUP LLP | Allergan plc | 24,934,153 | 7.4% | EDGAR |
SC 13G/A | 2019-02-11 | VANGUARD GROUP INC | Allergan plc | 24,179,830 | 7.2% | EDGAR |
SC 13G/A | 2019-02-04 | BlackRock Inc. | Allergan plc | 21,466,017 | 6.4% | EDGAR |
SC 13G/A | 2019-01-22 | GIC Private Ltd | Allergan plc | 15,494,156 | 4.6% | EDGAR |
SC 13D/A | 2018-02-12 | Allergan plc | TEVA PHARMACEUTICAL INDUSTRIES LTD | 36,291,067 | 3.6% | EDGAR |
SC 13G/A | 2018-02-08 | BlackRock Inc. | Allergan plc | 20,326,273 | 6.1% | EDGAR |
SC 13G/A | 2018-02-08 | GOLDMAN SACHS GROUP INC | Allergan plc | 2,177,282 | 0.7% | EDGAR |
SC 13G/A | 2018-02-08 | WELLINGTON MANAGEMENT GROUP LLP | Allergan plc | 21,498,689 | 6.5% | EDGAR |
SC 13G/A | 2018-02-08 | VANGUARD GROUP INC | Allergan plc | 22,980,194 | 6.9% | EDGAR |
SC 13G/A | 2018-01-26 | GIC Private Ltd | Allergan plc | 17,060,403 | 5.1% | EDGAR |
SC 13D/A | 2018-01-12 | Allergan plc | TEVA PHARMACEUTICAL INDUSTRIES LTD | 38,741,067 | 3.8% | EDGAR |
SC 13G | 2017-11-16 | GIC Private Ltd | Allergan plc | 16,989,047 | 5.1% | EDGAR |
SC 13D/A | 2017-11-13 | Allergan plc | TEVA PHARMACEUTICAL INDUSTRIES LTD | 70,291,067 | 6.9% | EDGAR |
SC 13D/A | 2017-11-01 | Allergan plc | TEVA PHARMACEUTICAL INDUSTRIES LTD | 70,291,067 | 6.9% | EDGAR |
SC 13G | 2017-02-14 | GOLDMAN SACHS GROUP INC | Allergan plc | 21,013,138 | 6.3% | EDGAR |
SC 13G | 2017-02-14 | GOLDMAN SACHS GROUP INC | Allergan plc | 21,013,138 | 6.3% | EDGAR |
SC 13G/A | 2017-02-09 | WELLINGTON MANAGEMENT GROUP LLP | Allergan plc | 22,689,449 | 6.8% | EDGAR |
SC 13G/A | 2017-02-09 | VANGUARD GROUP INC | Allergan plc | 24,042,947 | 7.2% | EDGAR |